Endocrinology, Vol 120, 1457-1464, Copyright © 1987 by Endocrine Society

ARTICLES

Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate

GS Prins

PRL augments testosterone-mediated growth of the prostate in a permissive manner. To elucidate the mechanism of this hormonal interaction, the present study examined the effect of PRL on cytosol and nuclear androgen receptors in the three prostate lobes. Adult male Sprague-Dawley rats were castrated, given 5-mm Silastic implants of testosterone, and either grafted with two anterior pituitary glands under the kidney capsule or sham operated. Three weeks later, animals were killed, serum was collected for PRL and testosterone RIA, and the ventral, dorsal, and lateral prostate lobes were processed for either cytosol or nuclear androgen receptor quantitation. Pituitary grafts significantly elevated the serum PRL concentration and increased the weight and the content of protein and DNA of the lateral prostate lobe compared to control values. There was no effect on these parameters in the ventral or dorsal lobes. Androgen receptor levels and apparent distributions were different in the ventral, dorsal, and lateral lobes of control animals. Unoccupied and total cytosolic androgen receptors in the three separate prostate lobes were not significantly affected by the presence of the grafts. However, an elevated PRL concentration was associated with an increase (P less than 0.005) in nuclear androgen receptor content in the lateral lobe exclusively. The binding affinity was not altered by pituitary grafts in any of the lobes. These findings suggest that PRL promotes lateral prostatic growth by increasing nuclear androgen receptor levels in that tissue and, thus, optimizes its response to circulating testosterone.

This article has been cited by other articles:

				N. Binart, N. Melaine, C. Pineau, H. Kercret, A. M. Touzalin, P. Imbert-Bollore, P. A. Kelly, and B. Jegou Male Reproductive Function Is Not Affected in Prolactin Receptor-Deficient Mice Endocrinology, September 1, 2003; 144(9): 3779 - 3782. [Abstract] [Full Text] [PDF]

				A. Omezzine, C. Mauduit, E. Tabone, N. Nabli, A. Bouslama, and M. Benahmed Caspase-3 and -6 Expression and Activation Are Targeted by Hormone Action in the Rat Ventral Prostate During the Apoptotic Cell Death Process Biol Reprod, September 1, 2003; 69(3): 752 - 760. [Abstract] [Full Text] [PDF]

				P. Harkonen Paracrine Prolactin May Cause Prostatic Problems Endocrinology, June 1, 2003; 144(6): 2266 - 2268. [Full Text] [PDF]

				J. P. Gilleran, O. Putz, M. DeJong, S. DeJong, L. Birch, Y. Pu, L. Huang, and G. S. Prins The Role of Prolactin in the Prostatic Inflammatory Response to Neonatal Estrogen Endocrinology, May 1, 2003; 144(5): 2046 - 2054. [Abstract] [Full Text] [PDF]

				T. J. Ahonen, P. L. Harkonen, H. Rui, and M. T. Nevalainen PRL Signal Transduction in the Epithelial Compartment of Rat Prostate Maintained as Long-Term Organ Cultures in Vitro Endocrinology, January 1, 2002; 143(1): 228 - 238. [Abstract] [Full Text] [PDF]

				X. Xu, E. Kreye, C. B. Kuo, and A. M. Walker A Molecular Mimic of Phosphorylated Prolactin Markedly Reduced Tumor Incidence and Size When DU145 Human Prostate Cancer Cells Were Grown in Nude Mice Cancer Res., August 1, 2001; 61(16): 6098 - 6104. [Abstract] [Full Text] [PDF]

				S. J. McPherson, H. Wang, M. E. Jones, J. Pedersen, T. P. Iismaa, N. Wreford, E. R. Simpson, and G. P. Risbridger Elevated Androgens and Prolactin in Aromatase-Deficient Mice Cause Enlargement, But Not Malignancy, of the Prostate Gland Endocrinology, June 1, 2001; 142(6): 2458 - 2467. [Abstract] [Full Text] [PDF]

				F. Van Coppenolle, C. Slomianny, F. Carpentier, X. Le Bourhis, A. Ahidouch, D. Croix, G. Legrand, E. Dewailly, S. Fournier, H. Cousse, et al. Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E120 - E129. [Abstract] [Full Text] [PDF]

				I. Leav, F. B. Merk, K. F. Lee, M. Loda, M. Mandoki, J. E. McNeal, and S.-m. Ho Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions Am. J. Pathol., March 1, 1999; 154(3): 863 - 870. [Abstract] [Full Text] [PDF]

				C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text]

				H. Wennbo, J. Kindblom, O. G. P. Isaksson, and J. Tornell Transgenic Mice Overexpressing the Prolactin Gene Develop Dramatic Enlargement of the Prostate Gland Endocrinology, October 1, 1997; 138(10): 4410 - 4415. [Abstract] [Full Text] [PDF]

				S. K. Clinton, A. L. Mulloy, S. P. Li, H. J. Mangian, and W. J. Visek Dietary Fat and Protein Intake Differ in Modulation of Prostate Tumor Growth, Prolactin Secretion and Metabolism, and Prostate Gland Prolactin Binding Capacity in Rats J. Nutr., February 1, 1997; 127(2): 225 - 237. [Abstract] [Full Text]